In a study published by Nam et al. in 2021 simvastatin treatment was shown to inhibit KRAS prenylation, resulting in induction of immunogenic cell death (ICD) in KRAS mutant CRC cells [37]. Here, KRAS is linked to colorectal carcinoma.